Biological and lifestyle factors linked to Alzheimer's risk in Black women

Understanding Biological and Lifestyle Contributions to Alzheimer's Disease Pathology and Clinical Profiles in Black Women: Defining Prevention Targets in High Risk Groups

NIH-funded research University of California, San Diego · NIH-11463178

This project looks at how inflammation, insulin resistance, and physical activity relate to brain tau changes and memory in older Black women at risk for Alzheimer's.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego NIH-funded
Lab location1 site (La Jolla, United States)
Project IDNIH-11463178 on NIH RePORTER

What this research studies

You would be part of research that measures blood markers of inflammation and insulin resistance, tracks physical activity, and tests thinking and memory over time. The team will use Alzheimer-related biomarkers (including phosphorylated tau), cognitive tests, and activity monitoring to see how these factors interact. The focus is specifically on older Black women who face higher rates of Alzheimer's to understand why their disease may progress faster. The goal is to identify modifiable targets that could help delay or prevent cognitive decline.

Who could benefit from this research

Good fit: Ideal candidates are Black women who are middle-aged or older and concerned about Alzheimer's risk, especially those with signs of inflammation, insulin resistance, or low physical activity.

Not a fit: People who are men, non-Black, or who already have advanced Alzheimer's dementia are unlikely to benefit directly from participation in this project.

Why it matters

Potential benefit: If successful, the findings could point to lifestyle or biological targets to help prevent or slow Alzheimer's disease in Black women.

How similar studies have performed: Prior studies show links between inflammation, activity, and brain health and suggest lifestyle changes can help, but focusing on tau biomarkers in Black women is a newer, less-tested approach.

Where this research is happening

La Jolla, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.